Drug Search Results
More Filters [+]

Nimorazole

Alternative Names: nimorazole
Latest Update: 2024-12-13
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Chile | India | Ireland | Italy | New Zealand | Pakistan | Peru | Russia | Taiwan | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Region Midtjylland
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Nimorazole

Countries in Clinic: Denmark, Norway

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Head and Neck Cancer|Squamous Cell Carcinoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

DAHANCA 30

P3

Unknown Status

Squamous Cell Carcinoma|Head and Neck Cancer

2029-12-01

Recent News Events